Blog
RSS FeedPosted by Michael Wonder on 27 Apr 2022
PHARMAC welcomes analysis into cancer medicines in Aotearoa
28 April 2022 - PHARMAC welcomes a new report released today by Te Aho o Te Kahu (the Cancer Control ...
Posted by Michael Wonder on 27 Apr 2022
Arthritis patients suffer after medication diverted due to COVID-19
27 April 2022 - Rheumatoid arthritis sufferers have been left in pain as one of their medications was diverted for ...
Posted by Michael Wonder on 11 Apr 2022
8,700 more Pacific peoples need treatment to prevent gout each year to achieve equity
11 April 2022 - PHARMAC has released the Pacific peoples health – Gout data insights report today. ...
Posted by Michael Wonder on 01 Apr 2022
Funding Trikafta for Kiwis with cystic fibrosis - setting the record straight
31 March 2022 - On Monday 28 March, Carmen Shanks presented her Parliamentary Petition to MP Shanan Halbert, urging the ...
Posted by Michael Wonder on 31 Mar 2022
New Zealand Pharmaceutical Schedule -1 April 2022
1 April 2022 - The April 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 Mar 2022
Statement from Rare Disorders NZ re Minister Little's comments on PHARMAC funding
31 March 2022 - Rare Disorders NZ is extremely frustrated to hear the Minister of Health this week dismiss the call ...
Posted by Michael Wonder on 31 Mar 2022
PHARMAC secures advance purchase agreement for a pre-exposure COVID-19 treatment
31 March 2022 - PHARMAC has negotiated an agreement with AstraZeneca for its pre-exposure prophylactic COVID-19 treatment, which would be targeted ...
Posted by Michael Wonder on 30 Mar 2022
Pfizer’s oral COVID-19 treatment arrives in New Zealand
31 March 2022 - The first shipment of Pfizer’s new oral antiviral treatment for COVID-19, Paxlovid, has arrived in New ...
Posted by Michael Wonder on 28 Mar 2022
Te Pāti Māori demand accountability from PHARMAC CE for lie about live saving Trikafta drug cost
28 March 2022 - Today Te Pāti Māori stand in solidarity with the cystic fibrosis community of Aotearoa New Zealand ...
Posted by Michael Wonder on 22 Mar 2022
Doctors break rules for prescribing safe-sex drug as PHARMAC considers change
22 March 2022 - Doctors flagrantly broke rules for prescribing a safe-sex drug during 2021 COVID-19 lockdowns. ...
Posted by Michael Wonder on 18 Mar 2022
Advocates say PHARMAC too slow on drugs to help treat COVID-19
19 March 2022 - Kiwis have been left waiting for a new antiviral drug to treat COVID-19 because PHARMAC was too ...
Posted by Michael Wonder on 17 Mar 2022
PHARMAC widening access to rituximab and zoledronic acid
17 March 2022 - PHARMAC is widening access to two medicines, rituximab and zoledronic acid, estimated to benefit 1,750 New Zealanders ...
Posted by Michael Wonder on 16 Mar 2022
PHARMAC deal good news for New Zealanders
16 March 2022 - The Government is welcoming news the national drug-funding agency PHARMAC has secured an agreement for medicines ...
Posted by Michael Wonder on 16 Mar 2022
PHARMAC to fund new treatments for lung and ovarian cancer
16 March 2022 - PHARMAC has confirmed today they are funding a bundle deal which will give New Zealanders more ...
Posted by Michael Wonder on 10 Mar 2022
Ronapreve: first COVID-19 therapeutic drug to get Medsafe's approval not effective against Omicron
10 March 2022 - The first new COVID-19 therapeutic drug to get Medsafe's approval demonstrates "significantly diminished potency" against Omicron. ...